Τόμος 12 (1998) – Τεύχος 1 & 2 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 12 (1998) – Issue 1 & 2 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on plasma ADH levels in normal and dehydrated rabbits
Authors Constantinos Kaliaras1, Nicolas Angelopoulos1, Michael Apostolakis1, Konstantinos Mavroudis2 and Ioannis Liangouris1

1. Department of Experimental Physiology, Faculty of Medicine, Aristotelion University of Thessaloniki, GR-540Q6, Thessaloniki, Greece

2. 2nd Division of Endocrinology, Alexandra Hospital, Athens, Greece

Citation Kaliaras, C., Angelopoulos, N., Apostolakis, M., Mavroudis, K., Liangouris, I.: Effects of intracerebroventricular administration of atrial natriuretic peptide (ANP) on plasma ADH levels in normal and dehydrated rabbits, Epitheorese Klin. Farmakol. Farmakokinet. 12(3): 23-30 (1998)
Publication Date Received for publication: 10 October 1997

Accepted for publication: 1 November 1997

Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords ANP, dehydration, intracerebroventricular, plasma ADH, rabbits.
Other Terms review article
Summary In order to investigate the effects of centrally administered Atrial Natriuretic Peptide (ANP) on plasma ADH levels, 20 male New Zealand White (NZW) rabbits were used. Measurements were made on restrained conscious animals one week after the implantation of an indwelling intracerebroventricular (icv) cannula and two indwelling intravascuiar catheters (intracarotid and intrajugular). Animals were classified into two main groups, those with water available ad libitum (euhydrated group) and those who were dehydrated for 24h (dehydrated group) before blood sampling for hormonal determination. Each group’s individuals were divided into two subgroups of five animals each. Blood samples were collected at 0 min (control) and 30, 60, 90, 120 min following icv administration of 25 μl of either artificial cerebrospinal fluid (aCSF) (subgroups aCSF) or human (h) ANP (1 μg) in aCSF (25 μl) (subgroups hANP). Plasma ADH concentrations were determined by RIA. The results were analysed by ANOVA. Dehydration resulted in an increase in ADH levels (p<0.0001) and icv administration of hANP prevented (p<0.05) in dehydrated+hANP experimental group the increase in ADH levels observed in the control dehydrated+aCSF group from 90 to 120 min. The increase of ADH in the control dehydrated groups could possibly be due to the combined stress stimulus of dehydration and restriction in the restrain box. These results indicate that centrally administered ANP, at the concentration achieved in the present study, does not decrease in conscious restrained euhydrated and 24h-dehydrated NZW rabbits the ADH response to dehydration, but does apparently modulate ADH response to other stimuli in the dehydrated state. In conclusion, the results of this study confirm that brain ANP may have an inhibitory effect on stimulated ADH release.
References 1.       Atlas S.A.: Atrial natriuretic factor: renal and systemic effects. Hosp. Pract. 21(7): 67- 77 (1986)

2.      Sudoh T., Minamino N., Kangawa K., Matsuo H.: C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168: 863-870 (1990)

3.      Sudoh T., Kangava K., Minamino N., Matsuo H.: A new natriuretic peptide in the porcine brain. Nature (Lond.) 332: 78-81 (1988)

4.      Imura H., Nakao K., Itoh H.: The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. Front. Neuroendocrinol. 13(3): 217- 249 (1992)

5.      Kawata M., Nakao K., Morii N., Kiso Y., Yamashita H., Imura H., Sano Y.: Atrial natriuretic polypeptide: topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry. Neuroscience 16: 521-546 (1985)

6.      Morii N., Nakao K., Sugawara A., Sakamoto M., Suda M., Shikomura M., Kiso Y., Kihara M., Yamori Y., Imura H.: Occurrence of atrial natriuretic polypeptide in brain. Biochem. Biophys. Res. Commun. 127: 413-419 (1985)

7.       Standaert D.G., Saper C.B., Needleman P.: Atriopeptin: Potent hormone and potential neuromediator. Trends Neurosci. 8: 509 (1985)

8.      Samson W.K.: Dehydration-induced alterations in rat brain vasopressin and atrial natriuretic factor immunoreactivity. Endocrinology 117: 1279-1281 (1985)

9.      Sugawara A.t Nakao K., Morii N., Sakamoto M., Suda M.( Shimokura M., Kiso Y., Kihara M., Yamori Y., Nishtmura K., Soneda J., Ban T., Imura H.: Alphahuman atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochem. Biophys. Res. Commun. 129: 439-446 (1985)

10.    Samson W.K.: Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 40: 277-279 (1985)

11.     Yamada T., Nakao K., Morll N., Itoh H., Shiono S., Sakamoto M., Sugawara A. et al.: Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats. Eur. J. Pharmacol. 125: 453-456 (1986)

12.    Keeler R.: Atrial natriuretic factor has a direct, prostaglandin-independent action on kidneys. Can. J. Physiol. Pharmacol. 60: 1078-1082 (1982)

13.    Shoji M., Kimura T., Matsui K., Ota K., Hake K., Inoue M. el al.: Effects of centrally administered atrial natriuretic peptide on renal functions. Acta Endocrinol. (Copenh) 115(4): 433-440 (1987)

14.    Lee J., Feng J.Q., Malvin R.L., Huang B.S., and Grekin R.J.: Centrally administered atrial natriuretic factor increases renal water excretion. Am. J. Physiol. 252(6Pt2): F1011-1015 (1987)

15.    Casto R., Keiler I., Schroeder G., and Stock G.: Angiotensin II induced vasopressin release is attenuated by central atrial natriuretic factor. Clin. Exp. Hypertens. [A] 9(1): SI- 94 (1987)

16.    Lee J., Malvin R.L., Claybaugh J.R., Huang B.S.: Atrial natriuretic factor inhibits vasopressin secretion in conscious sheep. Proc. Soc. Exp. Biol. Med. 185: 272-276 (1987)

17.     Laczi F., Vecsernyes M., Kovacs G.L., Penke B., Jojart I., Janaky T. et al.: The effect of atrial natriuretic factor on arginine-8-vasopressin and oxytocin levels in various brain regions and plasma. Exp. Clin. Endocrinol. 92(3): 328-334 (1988)

18.    Januszewicz P., Gutkowska J., DeLean A., Thibauit G., Garcia R., Genest J. et al.: Synthetic atrial natriuretic factor induces release (possibly receptor-mediated) of vasopressin from rat posterior pituitary. Proc. Soc. Exp. Biol. Med. 178: 321-325 (1985)

19.    Struthers A.D.: Atrial natriuretic factor. In: Frontiers in Pharmacology and Therapeutics (Flower R.J., George C.F., Hill R.G., eds.), p. 131, Blackwell, London, 1990

20.    Allen M.J., Ang V.T.Y., Bennett E.D., Jenkins J.S.: Atrial natriuretic peptide inhibits osmolality-induced arginine-vasopressin release in man. Clin. Sci. 75: 35-39 (1988)

21.    Williams T.D.M., Walsh K.P., Lightman S.L., Sutton R.: Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans. Am. J. Physiol. 255: R368-372 (1988)

22.    Itake K., Share L., Crofton J.T., Brooks D.P., Ouchi Y., Blaine E.H.: Central atrial natriuretic factor reduces vasopressin secretion in the rat. Endocrinology 119(1): 438-440 (1986)

23.    Sawyer C.H., Everett J.W., Green J.D.: The rabbit diencephalon in stereotaxic coordinates. J. Comp. Neurol. 101: 801-824 (1954)

24.    Hall L., DeLopez O., Roberts A., Smith F.: A procedure for chronic intravenous catheterization on the rabbit. Lab. Anim. Sci. 24: 79-83 (1974)

25.    Davson H., Dommer F.R., Hollingsworth J.K.: The mechanism of drainage of the cerebrospinal fluid. Brain 96: 329-336 (1973)

26.    Takahashi H., Okabayashi H., Suga K., Matsuzawa M., Inegaki I., Yoshimura M. et al.: Inhibitory roles of the hypothalamic atrial natriuretic polypeptide on the vasopressin release in the sodium-loaded rats. Biochem. Biophys. Res. Commun. 139: 1285-1291 (1986)

27.    Matthews S.G., Parrott R.F.: Centrally administered atriopeptin III reduces water intake and vasopressin secretion in dehydrated sheep. Peptides 12(1): 77-79 (1991)

28.    Szczepanska-Sadowska E., Oppermann C.S., Simon E., Gray D.A., Pleschka K., Szczypaczewska M.: Central ANP administration in conscious dogs responding to dehydration and hypovolemia. Am. J. Physiol. 262(5Pt2): R746-753 (1992)

29.    Trapani A.J., Undesser K.P., Keeton T.K., Bishop V.S.: Neurohumoral interactions in conscious dehydrated rabbits. Am. J. Physiol. 254: R338-347 (1988)

30.    Yamazaki T., Sagawa K.: Hypotension 1.5 min after 10% hemorrhage permits evaluation of rabbit’s baroreflex. Am. J. Physiol. 249 (Heart Circ Physiol 18): H450-456 (1985)

31.    Blessing W.W., Sved A.F., Reis D.J.: Destruction of noradrenergic neurons in rabbit brainstem elevates plasma vasopressin, causing hypertension. Science 17: 6162 (1982)

32.    Blessing W.W., Willoughby J.O.: Inhibiting the rabbit caudal ventrolateral medulla prevents baroreceptor-initiated secretion of vasopressin, J. Physiol. 367: 253-265 (1985)

33.    Shimizu T., Katsuura G., Nakamura M., Nakao K., Morll, N., Itoh Y., Shono S., Imura H.: Effect of intracerebroventricular atrial natriuretic polypeptide on blood pressure and urine production in rats. Life Sci. 39: 1263-1270 (1986)

34.    Thier S.O.: The Kidney. In: Pathophysiology. The Biological Principles of Disease. (Smith L.H., Thier S.O., eds.), p. 827, Saunders, Philadelphia, 1981

35.    Doczi T., Joo F., Szerdahelyi P., Bodosi M.: Regulation of brain water and electrolyte contents: the possible involvement of central atrial natriuretic factor. Neurosurgery 21(4): 454-458 (1987)

36.    Parkes D.G., Coglan J.P., Weisinger R.S., Scoggins B.A.: The effects of intracerebroventricular infusion of atrial natriuretic factor in conscious sheep. Peptides 9(3): 509-513 (1988)

37.    Januszewicz P., Larose P., Ong H., Gutkowska J., Genest J., Cantin M.: Effect of atrial natriuretic factor on plasma vasopressin in conscious rats. Peptides 7: 989-993 (1986)

38.    Schutz H., Gray D.A., Gerstberger R.: ANF-induced modulation of ADH release in the rabbit and Pekin duck. Prog. Brain Res. 91: 63-68 (1992)

39.    Crandall M.E., Gregg C.M.: In vitro evidence for an inhibitory effect of atrial natriuretic peptide on vasopressin release. Neuroendocrinology 44: 439-445 (1986)

40.    Steardo L., Nathanson J.: A. Brain barrier tissues: End organs for atriopeptins. Science 235: 470-473 (1987)

41.    Levin E.R , Weber M.A., Mills S.: Atrial natriuretic factor-induced vasodepression occurs through central nervous system. Am. J. Physiol. 255(3Pt2): H616-622 (1988)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 1998 – ANNUAL SUBSCRIPTION 1998
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά, Γαλλικά – English, French
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

Bookmark the permalink.

Comments are closed.